Global Blood Therapeutics prices a $200.0 million common stock public offering
Global Blood Therapeutics announced pricing of its underwritten public offering of 3,375,527 shares of its common stock for gross proceeds of $200.0 million. GBT has granted underwriter a 30-day option to purchase up to an additional $30.0 million of additional shares of common stock. June 26, 2019